ViBo Health provides an early warning system for detecting preventable disease with DigiScan™, an easy-to-use, accurate 10-second finger scanner.

Market:

Diabetes is one of the most pervasive and expensive diseases in the world. One in three Americans have prediabetes, yet 80% don’t know they have it. The cost of allowing prediabetes to go undetected and develop into Type 2 diabetes is enormous. In the U.S., $1 in every $4 spent on healthcare is for diabetes care. Employers pay $8,000 per year for each employee with diabetes. Preventing diabetes with early detection provides an ROI over 10 years of $55,000 per employee.

 

Technology:

DigiScan™, ViBo Health’s system under development, will transform early detection of prediabetes and disrupt the current diagnosis model, which misses 80% of cases. The tabletop scanner will be installed where consumers already go: high-traffic locations such as pharmacies, gyms, university campuses and workplaces. The platform uses a combination of magnetic resonance spectroscopy and predictive algorithms to measure and map a customer’s health, providing dynamic, actionable recommendations.

 

Advantages:

  • Accurate: detects multiple biomarkers
  • Accessible: Available in easy-to-access locations
  • User-friendly: No need for specialists
  • Quick: 10-second finger scan
  • Inexpensive: No cost to user

    Development Stage:

    • Prototype

    Patents Pending:

    • “METHODS AND APPARATUS FOR BENCHTOP METABOLITE PROFILING IN SITU”, PCT/US22/40369
    • “Health Trackers for Autonomous Targeting of Tissue Sampling Sites”, USPTO application No. 17848154
    • “MINIATURIZED MAGNETIC RESONANCE PROBE”, PCT/US13/501611
    • “Array Antenna Having a Radiation Pattern with a Controlled Envelope, and Method of Manufacturing it”, EP2697865B

      Select Publications:

      Contact:

      Website: https://vibo.health
      Phone: (310) 435-7172
      Email: info@vibo.health
      LinkedIn | Crunchbase

      Back to Top